Dapagliflozin and continuous glucose monitoring for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study compares two ways of managing type 2 diabetes: taking the drug dapagliflozin with a continuous glucose monitor (a small sensor that tracks sugar levels) versus traditional finger-prick testing. It aims to see if using the monitor helps control blood sugar better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have been diagnosed with type 2 diabetes within the last 5 years.
- You must NOT have taken any blood sugar-lowering medication in the past 3 months.
- Your recent A1c (average blood sugar over 3 months) must be between 7% and 9%.
- You should be able to use a smartphone, glucose monitor, smart scale, and wristband after training.
- You must not have severe health conditions like heart failure, advanced kidney or liver disease, or a history of repeated genital/urinary infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with type 2 diabetes use continuous glucose monitors (CGMs) and how these devices fit into their daily diabetes care. It aims to learn from your experience to improve support and guidance for others.
This trial tests if using a continuous glucose monitor (a small sensor that checks your sugar levels without fingersticks) helps young adults manage type 2 diabetes better. You will wear the sensor and use a phone app to track your glucose.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.